10 dollar share price, page-2

If LANI progresses well through the trials, and remember there are two quite different candidate molecules which are in Phase 1 trials, giving insurance should one fail or have side effects, I cannot see anything else which would compete with it in the near term. It will be a few years before it is ready for stockpiling but I see it as completely dominating the stockpiling market. In this case we could see
1. Much better royalty percentage
2. Near total market penetration